Loyal Funding & Investors
San Francisco, CA
Loyal is developing drugs to extend dog lifespan; we aim to build the defining aging company. Loyal was founded in early 2020 and has raised over $50M from Khosla, First Round Capital, Collaborative Fund, Longevity Fund, Quiet Capital, BoxGroup, and more. Loyal is working on bringing to market the first drugs intended to extend lifespan (years of life) and healthspan (quality of life). We aspire to build a pharma brand people love around deeply technical products. While we are currently focusing on dog drugs, our ultimate aim is to take what we learn in dogs to leapfrog into human aging drugs, and build the company that catalyzes and captures the public’s excitement around aging therapeutics.
https://loyalfordogs.com/Total Amount Raised: $115,000,000
Loyal Funding Rounds
Debt Financing
$12,000,000
Debt Financing Investors
Bridge BankSeries B
$45,000,000
Series B Investors
Bain Capital VenturesQuiet CapitalCollaborative FundKhosla VenturesThe Todd & Rahul Angel FundValor Equity PartnersFirst Round CapitalBoxGroupSeries A
$20,000,000
Series A
$27,000,000
Series A Investors
Khosla VenturesCollaborative FundThe Longevity FundFirst Round CapitalBoxGroupBrianne KimmelClaire Hughes JohnsonAshley MayerPredictive VCQuiet CapitalSeed
$11,000,000
Seed Investors
Ashley MayerThe Longevity FundBoxGroupCollaborative FundClaire Hughes JohnsonBrianne KimmelFirst Round CapitalVillage GlobalBossa Nova InvestimentosPareto HoldingsEdward Lando